Carcinoma of the male breast (MBC) is an uncommon phenomenon, accounting for 1 cm and/or presence of >1 metastatic axillary lymph node). Breast conserving surgery, performed in selected cases of male breast cancer, should be always followed by radiotherapy. Despite a wealth of small retrospective studies on MBC, its rarity means there is a lack of prospective randomized controlled treatment trials, which needs to be addressed if significant advances are to be made in the treatment of this unusual challenging disease.
|Number of pages||8|
|Journal||International Journal of Oncology|
|Publication status||Published - Mar 2004|
ASJC Scopus subject areas
- Cancer Research